$3.13
-0.05-1.57%
At close: -
$3.11
-0.02-0.64%
After Hours: Feb 21, 4:22 PM EDT
Comments
Loading...
Checkpoint Therapeutics (CKPT) Forecast
NewsEarningsCheckpoint Therapeutics (CKPT) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestCheckpoint Therapeutics (NASDAQ:CKPT) Stock Quotes, Forecast and News Summary
Checkpoint Therapeutics Stock (NASDAQ: CKPT) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Checkpoint Therapeutics (CKPT) stock?
You can purchase shares of Checkpoint Therapeutics (NASDAQ:CKPT) through any online brokerage.
Who are Checkpoint Therapeutics (CKPT) competitors?
Other companies in Checkpoint Therapeutics’s space includes: Adaptimmune Therapeutics (NASDAQ:ADAP), Genelux (NASDAQ:GNLX), RAPT Therapeutics (NASDAQ:RAPT), Lineage Cell Therapeutics (AMEX:LCTX) and Greenwich LifeSciences (NASDAQ:GLSI).
What is the forecast, or price target, for Checkpoint Therapeutics (CKPT) stock?
Checkpoint Therapeutics has a consensus price target of $24.29.
What is the current price for Checkpoint Therapeutics (CKPT)?
The stock price for Checkpoint Therapeutics (NASDAQ: CKPT) is $3.11 last updated February 21, 2025 at 4:22 PM EST.
Does Checkpoint Therapeutics (CKPT) pay a dividend?
There are no upcoming dividends for Checkpoint Therapeutics.
When is Checkpoint Therapeutics (NASDAQ:CKPT) reporting earnings?
Checkpoint Therapeutics’s Q1 earnings are confirmed for Friday, May 9, 2025.
Is Checkpoint Therapeutics (CKPT) going to split?
There is no upcoming split for Checkpoint Therapeutics.
What sector and industry does Checkpoint Therapeutics (CKPT) operate in?
Checkpoint Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.